scholarly article | Q13442814 |
P50 | author | Guy Boivin | Q90829727 |
Marie-Ève Hamelin | Q92970053 | ||
P2093 | author name string | Christian Couture | |
Melanie K Sackett | |||
P433 | issue | Pt 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Human metapneumovirus | Q743338 |
immunization | Q1415366 | ||
lung disease | Q3392853 | ||
P304 | page(s) | 3391-3400 | |
P577 | publication date | 2007-12-01 | |
P1433 | published in | Journal of General Virology | Q6295245 |
P1476 | title | Enhanced lung disease and Th2 response following human metapneumovirus infection in mice immunized with the inactivated virus | |
P478 | volume | 88 |
Q37124759 | A live attenuated human metapneumovirus vaccine strain provides complete protection against homologous viral infection and cross-protection against heterologous viral infection in BALB/c mice |
Q37713874 | Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection. |
Q47160156 | Detection of Nuclear Protein Profile Changes by Human Metapneumovirus M2-2 Protein Using Quantitative Differential Proteomics |
Q89860924 | Engineering of Live Chimeric Vaccines against Human Metapneumovirus |
Q89481911 | Evaluation of pre- and post-fusion Human metapneumovirus F proteins as subunit vaccine candidates in mice |
Q55012068 | Human metapneumovirus - what we know now. |
Q27694039 | Human metapneumovirus in adults |
Q27692700 | Human metapneumovirus: review of an important respiratory pathogen. |
Q26782209 | Immune Response to Human Metapneumovirus Infection: What We Have Learned from the Mouse Model |
Q45216908 | Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques |
Q40590076 | Metapneumovirus Infections and Respiratory Complications. |
Q34981539 | Modulation of protease activated receptor 1 influences human metapneumovirus disease severity in a mouse model |
Q38524373 | New Approaches for Immunization and Therapy against Human Metapneumovirus |
Q28474889 | Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets |
Q90417639 | Prophylactic and therapeutic approaches for human metapneumovirus |
Q27330166 | Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk |
Q38008607 | Recent developments with live-attenuated recombinant paramyxovirus vaccines |
Q27023742 | Recent vaccine development for human metapneumovirus |
Q92827733 | Role for maternal asthma in severe human metapneumovirus lung disease susceptibility in children |
Q60923277 | Small Animal Models of Respiratory Viral Infection Related to Asthma |
Q39166925 | Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice |